Cited by 903Cardiovascular Function and Risk FactorsCardiac Fibrosis and RemodelingCardiomyopathy and Myosin Studies

The DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.

Molecular mechanisms of diabetic cardiomyopathy

Open access

Bugger, Heiko, Abel, E. Dale·2014·Diabetologia

DOI 10.1007/s00125-014-3171-6PMC PMC3969857

Open this paper in CoChat — free account Open PDF

Abstract

In recent years, diabetes mellitus has become an epidemic and now represents one of the most prevalent disorders. Cardiovascular complications are the major cause of mortality and morbidity in diabetic patients. While ischaemic events dominate the cardiac complications of diabetes, it is widely recognised that the risk for developing heart failure is also increased in the absence of overt myocardial ischaemia and hypertension or is accelerated in the presence of these comorbidities. These diabetes-associated changes in myocardial structure and function have been called diabetic cardiomyopathy. Numerous molecular mechanisms have been proposed to contribute to the development of diabetic cardiomyopathy following analysis of various animal models of type 1 or type 2 diabetes and in genetically modified mouse models. The steady increase in reports presenting novel mechanistic data on this subject expands the list of potential underlying mechanisms. The current review provides an update on molecular alterations that may contribute to the structural and functional alterations in the diabetic heart.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-014-3171-6

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

MicroRNA miR-133 Represses HERG K+ Channel Expression Contributing to QT Prolongation in Diabetic Hearts
Xiao, J., Luo, X., Lin, H., Zhang, Y., Lu, Y., Wang, N., Zhang, Y., Yang, B., & Wang, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700015200 · Cited by 233
Retracted
Retracted: Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up‐regulation contribute to the onset of diabetic cardiomyopathy
Ma, H., Li, S., Xu, P., Babcock, S. A., Dolence, E. K., Brownlee, M., Li, J., & Ren, J. T. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00547.x · Cited by 154
Retracted
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Development by Self-Digestion
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,728
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
The Framingham Study
Dawber, T. R. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674492097 · Cited by 1,965
Identification of hundreds of conserved and nonconserved human microRNAs
Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., Barzilai, A., Einat, P., Einav, U., Meiri, E., et al. (2005) · Nature Genetics · doi:10.1038/ng1590 · Cited by 1,841
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,835
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress
Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1574 · Cited by 1,520

Show all 153 references

Sorted by citations

Items 601–700 of 903

Cissus quadrangularis extract mitigates diabetic cardiomyopathy by inhibiting RAAS activation, inflammation and oxidative stress
Syed, A. A., Reza, M. I., Shafiq, M., Kumariya, S., Katekar, R. A., Hanif, K., & Gayen, J. R. (2022) · Biomarkers · doi:10.1080/1354750x.2022.2107703 · Cited by 9
The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy
Xia, W., Li, X., Wu, Q., Xu, A., Zhang, L., & Xia, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.951381 · Cited by 8
Short-term caloric restriction in db/db mice improves myocardial function and increases high molecular weight (HMW) adiponectin
Xu, X. J., Babo, E., Qin, F., Croteau, D., & Colucci, W. S. (2016) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2016.10.002 · Cited by 8
Double‐stranded RNA‐dependent protein kinase signalling and paradigms of cardiometabolic syndrome
Kalra, J., & Dhar, A. (2016) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12261 · Cited by 8
Molecular imaging of postprandial metabolism
Schrauwen‐Hinderling, V. B., & Carpentier, A. C. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00212.2017 · Cited by 8
The emerging role of circular RNAs in cardiovascular diseases
Ding, Y., Lu, C., Zhang, W., Wang, Y., Li, Y., Zhu, Y., Lv, S., & Zhang, J. (2021) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-021-00807-y · Cited by 8
Non-ischemic diabetic cardiomyopathy may initially exhibit a transient subclinical phase of hyperdynamic myocardial performance
Hensel, K. O. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.06.002 · Cited by 8
Novel impact of metal ion-induced cell death on diabetic cardiomyopathy pathogenesis and therapy
Jiang, J., Hu, S., Hu, K., Xiao, L., Lin, J., Chen, Y., Zhang, D., Ou, Y.-L., Zhang, J., Yuan, L., et al. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02090-4 · Cited by 8
Deep phenotyping of a modified diabetic cardiomyopathy mouse model which reflects clinical disease progression
Karuna, N., Kerrigan, L., Edgar, K. S., Cappa, O., Simpson, D. A. C., Tonry, C. L., Grieve, D. J., & Watson, C. J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01913-3 · Cited by 7
PANoptosis: a potential target of cardiomyopathy
Sun, M., Lu, C., Wei, J., Gao, C., & Dong, D. F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1704465 · Cited by 7
Metformin Inhibits Inflammation by Targeting the NLRP3 Inflammasome: Linking NF-κB/NEK7/AMPK Signaling to Mitochondrial Function
Ning, D., Jiang, C., Zeng, J., Zeng, F., Zheng, X., Xia, P., Liu, Y., (11077), X. H., Zhang, D., Liu, X., et al. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s570735 · Cited by 8
Chronic Hyperglycaemia Inhibits Tricarboxylic Acid Cycle in Rat Cardiomyoblasts Overexpressing Glucose Transporter Type 4
Stratmann, B., Eggers, B., Mattern, Y., de Carvalho, T. S., Marcus, K., & Tschoepe, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137255 · Cited by 7
N-acetylcysteine combined with insulin attenuates myocardial injury in canines with type 1 diabetes mellitus by modulating TNF-α-mediated apoptotic pathways and affecting linear ubiquitination
Huang, J., Pang, X., Zhang, X., Qiu, W., Zhang, X., Wang, R., Xie, W., Bai, Y., Zhou, S., Liao, J., et al. (2023) · Translational research · doi:10.1016/j.trsl.2023.07.003 · Cited by 7
Duodenal‐jejunal bypass surgery activates eNOS and enhances antioxidant system by activating AMPK pathway to improve heart oxidative stress in diabetic cardiomyopathy rats
Yang, G., Liu, Z., Dong, S., Zhao, X., Ge, Z., Cheng, Z., Zhang, X., & Wang, K. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13516 · Cited by 7
Combination of ADAM17 knockdown with eplerenone is more effective than single therapy in ameliorating diabetic cardiomyopathy
Xie, L., Zang, D., Yang, J., Xue, F., Sui, W., & Zhang, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1364827 · Cited by 7
The diagnostic sensitivity of circulating cardio-enriched microRNAs is increased after normalization of high-density lipoprotein levels
Ram, T. P., Fomison‐Nurse, I. C., Gandhi, S., Coffey, S., Saxena, P., Galvin, I. F., Bunton, R. W., Williams, M. J. A., Lamberts, R. R., & Katare, R. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.01.119 · Cited by 7
Naringenin alleviates high D-glucose-induced injuries through upregulation of microRNA-30d-5p level in human AC16 cardiac cells
Jiang, J., Liang, G., Wu, Z., Mo, H., You, Q., Wang, Z., Wu, K., & Guo, R. (2018) · Journal of Applied Biomedicine · doi:10.1016/j.jab.2018.02.005 · Cited by 7
Diabetic cardiomyopathy: acute and reversible left ventricular systolic dysfunction due to cardiotoxicity of hyperglycaemic hyperosmolar state—a case report†
Kocabaş, U., Yılmaz, Ö., & Kurtoğlu, V. (2019) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytz049 · Cited by 7
Differential Effect of Cardiac Resynchronization Therapy in Patients with Diabetes Mellitus: A Long-Term Retrospective Cohort Study
Kahr, P. C., Trenson, S., Schindler, M., Kuster, J., Kaufmann, P. A., Tonko, J., Höfer, D., Inderbitzin, D., Breitenstein, A., Saguner, A. M., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12876 · Cited by 8
Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication
Lichtenauer, M., Jirak, P., Paar, V., Sipos, B., Kopp, K. L., & Berezin, A. Е. (2021) · Applied Sciences · doi:10.3390/app11104397 · Cited by 8
Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease?
Bowman, P. R. T., Smith, G. L., & Gould, G. W. (2021) · PeerJ · doi:10.7717/peerj.11485 · Cited by 8
Reduced Fatty Acid Use from CD36 Deficiency Deteriorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice
Umbarawan, Y., Kawakami, R., Syamsunarno, M. R. A. A., Obinata, H., Yamaguchi, A., Hanaoka, H., Hishiki, T., Hayakawa, N., Koitabashi, N., Sunaga, H., et al. (2021) · Metabolites · doi:10.3390/metabo11120881 · Cited by 7
Fufang Xueshuantong Improves Diabetic Cardiomyopathy by Regulating the Wnt/β-Catenin Pathway
Peng, M., Liu, H., Ji, Q., Ma, P., Niu, Y., Ning, S., Sun, H., Pang, X., Yang, Y., Zhang, Y., et al. (2022) · International Journal of Endocrinology · doi:10.1155/2022/3919161 · Cited by 7
Disparate Clinical Characteristics and Prognosis of HFpEF versus HFrEF Phenotype of Diabetic Cardiomyopathy
Li, Z., Shi, Y. P., Xia, Y., Wu, L., Li, H., Zhou, R., Gao, X., Zhang, H., Jin, X., & Zhang, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041565 · Cited by 7
Urocortin 2 Gene Transfer Reduces the Adverse Effects of a Western Diet on Cardiac Function in Mice
Kim, Y. C., Giamouridis, D., Lai, N., Guo, T., Xia, B., Fu, Z., Gao, M. H., & Hammond, H. K. (2019) · Human Gene Therapy · doi:10.1089/hum.2018.150 · Cited by 7
Conditional knockout of pyruvate dehydrogenase in mouse pancreatic β‑cells causes morphological and functional changes
Wang, X., Lai, S., Ye, Y., Hu, Y., Pan, D.-Y., Bai, X., & Shen, J. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.10993 · Cited by 8
Important Considerations for the Treatment of Patients with Diabetes Mellitus and Heart Failure from a Diabetologist’s Perspective: Lessons Learned from Cardiovascular Outcome Trials
Koliaki, C. C., & Katsilambros, N. L. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17010155 · Cited by 7
MiRNA Regulates Ferroptosis in Cardiovascular and Cerebrovascular Diseases
Liu, Y., Yang, P., Wang, J., Wu, P., Zhao, J., & Wang, Z. (2024) · DNA and Cell Biology · doi:10.1089/dna.2024.0135 · Cited by 6
Protective Effects of Flavonoids in Diabetic Cardiomyopathy: A Comprehensive Review on the Mechanistic Insights
Ramos, S. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70038 · Cited by 6
Dapagliflozin alleviates mitochondrial damage in the myocardium under diabetic conditions by targeting sortilin
Gao, Y., Li, E., Li, F., Cui, Y., Shu, Q., Zhang, Y., Kong, L., Li, H., & Yang, X. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05793-8 · Cited by 7
Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy
Zhao, L., Freiberg, S. M., Music, M. L., Gu, L., Nacos, S., Phillips, J. P., Hassan, A., Shibbani, K., Munir, S. S., Kumar, V. K., et al. (2025) · Basic Research in Cardiology · doi:10.1007/s00395-025-01136-7 · Cited by 6
Self-citation
Pharmacological modulation of prostaglandin E2 (PGE2) EP receptors improves cardiomyocyte function under hyperglycemic conditions
Bosma, K. J., Ghosh, M., Andrei, S. R., Zhong, L., Dunn, J. C., RICCIARDI, V. F., Burkett, J. B., Hatzopoulos, A. K., Damron, D. S., & GANNON, M. A. (2022) · Physiological Reports · doi:10.14814/phy2.15212 · Cited by 6
MicroRNA‑378: An important player in cardiovascular diseases (Review)
Wang, H., Shi, J., Wang, J., & Hu, Y. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13059 · Cited by 6
Assessment of subclinical left ventricular myocardial systolic dysfunction in type 2 diabetes mellitus patients with or without hypertension by global and segmental myocardial work
Li, G.-A., Huang, J., Xiao, S., & Fan, L. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01180-0 · Cited by 6
Early detection of myocardial involvement by non-contrast T1ρ mapping of cardiac magnetic resonance in type 2 diabetes mellitus
Shu, H., Xu, H., Pan, Z., Liu, Y., Deng, W., Zhao, R., Sun, Y., Wang, Z., Yang, J., Gao, H., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1335899 · Cited by 6
Role of 8-hydroxyguanine DNA glycosidase 1 deficiency in exacerbating diabetic cardiomyopathy through the regulation of insulin resistance
Li, X., Wu, Z., Fan, J.-Y., Liu, M., Song, C., Chen, H., Yin, Y., Li, A., Wang, Y., Gao, S., et al. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.05.012 · Cited by 6
YAP1-mediated dysregulation of ACE-ACE2 activity augments cardiac fibrosis upon induction of hyperglycemic stress
Mondal, A., Das, S., Das, M., Chakraborty, S., & Sengupta, A. (2024) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2024.130666 · Cited by 5
Female Psammomys obesus Are Protected from Circadian Disruption-Induced Glucose Intolerance, Cardiac Fibrosis and Adipocyte Dysfunction
Tan, J. T. M., Cheney, C. V., Bamhare, N. E. S., Hossin, T., Bilu, C., Sandeman, L., Nankivell, V. A., Solly, E. L., Kronfeld‐Schor, N., & Bursill, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137265 · Cited by 6
PEDF Overexpression Ameliorates Cardiac Lipotoxicity in Diabetic Cardiomyopathy via Regulation of Energy Metabolism
Mao, T., & Ye, W. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s482346 · Cited by 6
Perillaldehyde targeting PARP1 to inhibit TRPM2-CaMKII/CaN signal transduction in diabetic cardiomyopathy
Niu, Q., Fu, Z.-Z., Mao, B.-Y., Zhang, X., Wang, H. Q., Li, P., lin, L.-B., Xi, Y.-T., Yin, Y., Kamal, N. N. S. N. M., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114291 · Cited by 6
The joint association of diabetes status and NT-ProBNP with adverse cardiac outcomes in patients with non-ST-segment elevation acute coronary syndrome: a prospective cohort study
Wang, M., Su, W., Chen, H., & Li, H. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01771-1 · Cited by 6
Mitochondrial H2O2 metabolism as central event of heart complex I syndrome in early diabetes
Rukavina-mikusic, I. A., Rey, M., Areán, J. S. A., Vanasco, V., Álvarez, S., & Valdez, L. B. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.03.011 · Cited by 6
Effects of non-coding RNAs and RNA-binding proteins on mitochondrial dysfunction in diabetic cardiomyopathy
Potel, K. N., Cornelius, V. A., Yacoub, A., Chokr, A., Donaghy, C. L., Kelaini, S., Eleftheriadou, M., & Margariti, A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1165302 · Cited by 6
Curcumin-mediated effects on anti-diabetic drug-induced cardiotoxicity
Jain, A., & Rani, V. (2018) · 3 Biotech · doi:10.1007/s13205-018-1425-6 · Cited by 7
Role of histone deacetylase inhibitors in diabetic cardiomyopathy in experimental models (Review)
Garmpi, A., Damaskos, C., Garmpis, N., Kaminiotis, V. V., GEORGAKOPOULOU, V. E., Spandidos, D. A., Papalexis, P., Diamantis, E., Patsouras, A., Kyriakos, G., et al. (2022) · Medicine International · doi:10.3892/mi.2022.51 · Cited by 6
Adverse impact of diabetes mellitus on left ventricular remodelling in patients with chronic primary mitral regurgitation
Ernande, L., Beaudoin, J., Piro, V., Meziani, S., & Scherrer‐Crosbie, M. (2018) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2017.10.004 · Cited by 6
Generating Ins2+/−/miR-133aTg Mice to Model miRNA-Driven Cardioprotection of Human Diabetic Heart
Shahshahan, H. R., Kambis, T. N., Kar, S., Yadav, S. K., & Mishra, P. K. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1008-4_8 · Cited by 6
Protective role of the Atg8 homologue Gabarapl1 in regulating cardiomyocyte glycophagy in diabetic heart diseasePreprint
Mellor, K. M., Varma, U., Koutsifeli, P., Curl, C. L., Janssens, J. V., Daniels, L. J., Bernasochi, G. B., Raaijmakers, A. J. A., Benson, V. L., Chan, E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.21.449174 · Cited by 6
Impaired autophagy flux contributes to enhanced ischemia reperfusion injury in the diabetic heart
Tang, J., Yoon, N., Dadson, K., Sung, H. K., Lei, Y., Dang, T. Q., Chung, W. Y., Ahmed, S., Sater, A. A. A., Wu, J., et al. (2024) · Autophagy Reports · doi:10.1080/27694127.2024.2330327 · Cited by 5
MicroRNAs as regulators of cardiac dysfunction in sepsis: pathogenesis and diagnostic potential
Liu, Z., Li, F., Li, N., Chen, Y., & Chen, Z. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1517323 · Cited by 5
Hyperglycaemia‐induced reactive oxygen species production in cardiac ventricular myocytes differs among mammals
Lu, S., Baier, M. J., Pölönen, R.-P., Liao, Z., Martin, J. W., Ginsburg, K. S., Mustroph, J., & Bers, D. M. (2025) · The Journal of Physiology · doi:10.1113/jp287886 · Cited by 5
Irisin Protects Against Diabetic Cardiomyopathy by Suppressing Ferroptosis
Ye, H., Guo, J., Wang, X., Chen, B., Hu, L., Liu, B., Song, R., Feng, Y., & Zhang, X. (2025) · Drug Development Research · doi:10.1002/ddr.70077 · Cited by 5
Type 2 diabetes worsens the outcome of ischemia/reperfusion in female STEMI patients and female db/db mice with HFpEF cardiometabolic phenotype
Iveljić, I., Young, M., Corhodzic, E., Cullen, F., Prag, H. A., Murphy, M. P., & Aksentijević, D. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02771-z · Cited by 5
The E2F family: a ray of dawn in cardiomyopathy
Wei, J., Gao, C., Lu, C., Wang, L., Dong, D., & Sun, M. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05063-4 · Cited by 6
The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community
Dong, L., Shi, G., Xu, M., Yin, J., Liu, Y., Yang, J., & Xu, L. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14162 · Cited by 5
Role of bariatric surgery in improving diabetic cardiomyopathy: Molecular mechanisms and therapeutic perspectives (Review)
Song, K., Liang, D., Xiao, D., Kang, A., & Ren, Y. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13323 · Cited by 5
Comparative proteomics analysis ofmyocardium inmouse model of diabetic cardiomyopathy using the iTRAQ technique
Shao, M., Chen, J., & Zheng, S. (2018) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/74539 · Cited by 5
De la diabetes a la insuficiencia cardiaca ¿Existe la miocardiopatía diabética?
Saldarriaga, C., Navas, V., & Morales, C. (2020) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2019.12.006 · Cited by 5
The role of sodium glucose co-transporter inhibitors in heart failure prevention
Garla, V. V., Subauste, A. R., Butler, J., & Lien, L. F. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107811 · Cited by 5
Cardiac Metabolism and Contractile Function in Mice with Reduced Trans-Endothelial Fatty Acid Transport
Iso, T., & Kurabayashi, M. (2021) · Metabolites · doi:10.3390/metabo11120889 · Cited by 5
Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress
Zhang, L., Hu, C., Jin, B. R., Bai, B., Liao, J., Jin, L., Wang, M., Zhu, W., Wu, X., Li, Z., et al. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07426-3 · Cited by 5
Molecular insights into diabetic cardiomyopathy
Barman, C., Pandey, R., Singh, J., & Sodhi, K. S. (2015) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20150230 · Cited by 5
Gender-Dependent Alteration of Ca2+ and TNFα Signaling in db/db Mice, an Obesity-Linked Type 2 Diabetic Model
Delgado, C., Gomez, A. M., Hayek, M. S. E., Ruiz‐Hurtado, G., & Pereira, L. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00040 · Cited by 5
Alterations in Cardiac Metabolism in Heart Failure
Bugger, H., Wende, A. R., & Abel, E. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00017-x · Cited by 5
Self-citation
Therapeutic effects of finerenone and exenatide on diabetes-induced heart failure: A combined approach targeting inflammation and oxidative stress
Koçak, A., gunek, E., Aydın, E., Gündüz, M. K., & Kaymak, G. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177826 · Cited by 4
Pharmacological advances in multi-targeted strategies for type 2 diabetes mellitus: a systematic perspective based on traditional Chinese medicine
Zhao, Y.-L., Liao, J.-B., Pang, P., Li, J.-Y., Su, S.-C., Shao, M., Wen, W., & Xu, F.-R. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1732134 · Cited by 6
Autophagy as a therapeutic linchpin in metabolic diseases and obesity-associated diabetes
Vakili, O., Klionsky, D. J., Reiter, R. J., Ren, J., Deshpande, A., Ahn, K. S., Cho, W., Hushmandi, K., & Kumar, A. P. (2026) · Autophagy · doi:10.1080/15548627.2026.2636096 · Cited by 7
Role of gasotransmitters in necroptosis
Cao, L., Wang, X., Chu, T., Wang, Y., Fan, Y.-Q., Chen, Y.-H., Zhu, Y., Zhang, J., Ji, X., & Wu, D. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114233 · Cited by 4
Mitochondrial Dysfunction as a Therapeutic Target in Diabetic Cardiomyopathy: Progress and Prospects
Zhang, F., Li, Z., Wang, Y., Li, C., & Lu, C. (2025) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2024.0063 · Cited by 4
A Molecular Perspective on the Intricate Interplay Among Exosomes, Bioenergetic Metabolism, and the Pathogenesis of Diabetic Cardiomyopathy
Renu, K. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10655-6 · Cited by 4
Carbon Nitride Nanocomposite-Based Electrochemiluminescence Biosensor Platform for In Vitro Detection of Diabetic Cardiomyopathy Markers
Kumar, A., Chaulagain, N., Fande, S., Shankar, K., & Goel, S. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c03298 · Cited by 4
Jianpi Qinghua Formula Alleviates Diabetic Myocardial Injury Through Inhibiting JunB/c-Fos Expression
Wang, L., Chen, Q., & Lu, H. (2024) · Current Medical Science · doi:10.1007/s11596-024-2830-1 · Cited by 4
Subclinical impairment of left ventricular myocardium function in type 2 diabetes mellitus patients with or without hypertension
Chen, Z.-G., Li, G.-A., Jun, H., & Li, F. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i6.1272 · Cited by 4
Role of the receptor for advanced glycation end products in the severity of SARS-CoV-2 infection in diabetic patients
Pedreáñez, A. B., Mosquera-Sulbarán, J., & Tene, D. M. (2024) · Diabetology International · doi:10.1007/s13340-024-00746-1 · Cited by 5
Chronic inorganic nitrate supplementation does not improve metabolic health and worsens disease progression in mice with diet-induced obesity
Sowton, A. P., Holzner, L. M. W., Krause, F. N., Baxter, R. M., Mocciaro, G., Krzyzanska, D., Minnion, M., O’Brien, K. A., Harrop, M. C., Darwin, P. M., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00256.2024 · Cited by 6
Diabetic Cardiomyopathy: A Forensic Perspective
McGuire, A. R., & Gill, J. R. (2016) · Academic Forensic Pathology · doi:10.23907/2016.021 · Cited by 4
Is the longitudinal deformation of the left ventricle affected by vitamin D deficiency in nondiabetics? A 2D speckle‐tracking echocardiographic study
Omidi, F., & Hosseinsabet, A. (2018) · Echocardiography · doi:10.1111/echo.14205 · Cited by 4
Zucker Diabetic Sprague Dawley (ZDSD) Rat, A Spontaneously Diabetic Rat Model Develops Cardiac Dysfunction and Compromised Cardiac Reserve
Sun, G., Zhang, G., Jackson, C. V., & Wang, Y. (2018) · Cardiology Research and Cardiovascular Medicine · doi:10.29011/2575-7083.000033 · Cited by 4
Effect of Musk Tongxin Dropping Pill on Myocardial Remodeling and Microcirculation Dysfunction in Diabetic Cardiomyopathy
Zhao, J., Zhou, Y., Liu, H., Zheng, Z., Liu, S., Peng, J., Guo, H., Tang, W., & Peng, F. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6620564 · Cited by 4
RETRACTED: STK35 Gene Therapy Attenuates Endothelial Dysfunction and Improves Cardiac Function in Diabetes
Joladarashi, D., Zhu, Y., Willman, M., Nash, K. R., Cimini, M., Thandavarayan, R. A., Youker, K. A., Song, X., Ren, D., Li, J., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.798091 · Cited by 4
Retracted
Effect of sodium-glucose co-transporter-2 inhibitors on right ventricular function in patients with type 2 diabetes mellitus: A pilot study
Patoulias, D., Toumpourleka, M., Katsimardou, A., Zografou, I., Stavropoulos, K., Imprialos, K. P., Karagiannis, A. I., Doumas, M. N., & Papadopoulos, C. E. (2022) · Kardiologia Polska · doi:10.33963/kp.a2022.0104 · Cited by 4
Dynamic evolution and mechanism of myocardial glucose metabolism in different functional phenotypes of diabetic cardiomyopathy — a study based on 18 F-FDG microPET myocardial metabolic imaging
Shao, X., Liu, Y., Zhou, M., Xu, M., Chen, Y., Huang, H., Lin, J., & Wang, Y. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01038-5 · Cited by 4
Preclinical Evidence for the Effectiveness of Mesenchymal Stromal Cells for Diabetic Cardiomyopathy: A Systematic Review and Meta-analysis
Liu, B., Zhang, J., Zhou, Z., Feng, B., He, J., Yan, W., Zhou, X., Amponsah, A. E., Guo, R., Du, X., et al. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230510111302 · Cited by 4
Diabetic cardiomyopathy: Role of epidermal growth factor receptor tyrosine kinase
Xu, Z., & Cai, L. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.04.002 · Cited by 4
Sheng Mai San protects H9C2 cells against hyperglycemia-induced apoptosis
Pang, B., Shi, L., Du, L., Li, Y.-C., Zhang, M., & Ni, Q. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2694-2 · Cited by 4
A Study of Rat Myocardial Na/K-ATPase Activity in Experimental Conditions of Prediabetes and Diabetes Mellitus
Chistyakova, O. V., Sukhov, I. B., Dobretsov, M. G., & Kubasov, I. V. (2020) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093020020118 · Cited by 4
Cardiomiopatía diabética
Araújo, A. S. P. (2017) · Revista Uruguaya de Cardiología · doi:10.29277/ruc/32.3.7 · Cited by 4
Quantitative proteomic analysis reveals high interference on protein expression of H9c2 cells activated with glucose and cardiotonic steroids
Meneses, E. P., Hernández-Orihuela, L., Pando-Robles, V., López, T. D., Osés-Prieto, J. A., Burlingame, A. L., & Batista, C. V. F. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.103536 · Cited by 4
Goreisan suppresses cardiac remodeling and dysfunction in a new mouse model with diabetic cardiomyopathy
Funamoto, M., Hirose, S., Yamamoto, M., Ly-Nguyen, H. D., Imanishi, M., Ebi, F., Ito, M., Ohminami, H., Tsuchiya, K., & Ikeda, Y. (2025) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2025.01.003 · Cited by 3
Impaired hemodynamic forces assessed by routine CMR and its determinants in different duration T2DM patients with normal LV function and myocardial strain
Shao, G., Cao, Y., Cui, Y., Li, H., & Shi, H. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1460094 · Cited by 3
Loganic acid ameliorates diabetic cardiomyopathy via suppressing TLR4/p38 MAPK signaling-mediated oxidative stress and inflammation
Ding, X., Wang, J., Huang, X., & Huang, J. (2025) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.25-91 · Cited by 3
FGF9 alleviates diabetic cardiomyopathy by activating Nrf2 via SQSTM1/p62-Keap1 in mice
An, N., Chen, Y., Li, L., Wang, B., Zhou, X., & Chen, G. (2025) · Communications Biology · doi:10.1038/s42003-025-09077-6 · Cited by 4
Inflammasome-Driven Cardiac Fibrosis in Cardiometabolic Disease and Arrhythmias: Mechanisms, Biomarkers, and Therapeutic Targets
Grigoriou, K., Lamprou, V., Antoniadis, A. P., Theofilis, P., Iliakis, P., Ktenopoulos, N., Apostolos, A., Nasoufidou, A., Fyntanidou, B., Karagiannidis, E., et al. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl48667 · Cited by 3
Cardiovascular protective properties of gastrodin
Yang, S.-T., & Liu, S. (2022) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/2221-1691.340558 · Cited by 3
Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy
Shafaati, T., & Gopal, K. (2024) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.3389/jpps.2024.13193 · Cited by 3
Beta-adrenergic agonism protects mitochondrial metabolism in the pancreatectomised rat heart
Lindsay, R. T., Thisted, L., Zois, N. E., Thrane, S. T., West, J. A., Fosgerau, K., Griffin, J. L., Fink, L. N., & Murray, A. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-70335-4 · Cited by 3
Modulation of GLP-1 signalling as an innovative strategy counteracting the onset of heart failure: Potential for natural compound supplementation
Gliozzi, M., Coppoletta, A. R., Cardamone, A., Carresi, C., Mollace, R., Musolino, V., & Mollace, V. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107744 · Cited by 3
Role of gut microbiota and its metabolites in diabetic cardiomyopathy: from pathogenesis to interventions
Ji, Z., Yu, X., Gu, H., Wang, P., Meng, L., Lin, H., & Lv, H. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1677684 · Cited by 3
Imaging Myocardial Metabolism
Gropler, R. J., & Malloy, C. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-61401-4_11 · Cited by 2
Oxidized Lipoproteins as the Diagnostic Target for Cardiovascular Diseases
Sreeja, S., Manoharan, A., & Venkataraman, K. (2018) · Current Science · doi:10.18520/cs/v115/i7/1276-1286 · Cited by 2

Authors: Bugger, H., & Abel, E. D.
Affiliations: University of Freiburg (DE)
University of Iowa (US)
Corresponding author: Abel, E. Dale
ORCID: Bugger, Heiko
Abel, E. Dale
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2014-01-30
Volume: 57
Issue: 4
Pages: 660-671
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-014-3171-6
PMC: PMC3969857
OpenAlex: W2006499762
Cited by: 903
References: 153
Citations by year: 2026: 51 · 2025: 76 · 2024: 75 · 2023: 79 · 2022: 95 · 2021: 103 · 2020: 100 · 2019: 66 · 2018: 84 · 2017: 62 · 2016: 54 · 2015: 43 · 2014: 14
FWCI: 9.29
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01HL108379, U01HL087947)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK092065)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords: diabetic cardiomyopathy, diabetes mellitus, heart failure, myocardial structure and function, type 1 diabetes, type 2 diabetes, animal models of diabetes, genetically engineered mouse models, cardiovascular complications of diabetes
MeSH terms: Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Heart Failure, Humans, Diabetic Cardiomyopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular mechanisms of diabetic cardiomyopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks